{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:09:54Z","timestamp":1772604594035,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,6,5]],"date-time":"2011-06-05T00:00:00Z","timestamp":1307232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00702-011-0666-x","type":"journal-article","created":{"date-parts":[[2011,6,4]],"date-time":"2011-06-04T04:48:35Z","timestamp":1307162915000},"page":"25-30","source":"Crossref","is-referenced-by-count":12,"title":["The effect of selegiline on total scavenger capacity and liver fat content: a preliminary study in an animal model"],"prefix":"10.1007","volume":"119","author":[{"given":"Gabor","family":"Bekesi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"Tulassay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzsa","family":"Schaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dezso","family":"Szombath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Stark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istvan","family":"Marczell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Nagy-Repas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ildiko","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elek","family":"Dinya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karoly","family":"Racz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalman","family":"Magyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,5]]},"reference":[{"key":"666_CR1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/0024-3205(80)90025-9","volume":"27","author":"R Adolfsson","year":"1980","unstructured":"Adolfsson R, Gottfries CG, Oreland L, Wiberg A, Winblad B (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 27:1029\u20131034","journal-title":"Life Sci"},{"key":"666_CR2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01253131","volume":"36","author":"W Birkmayer","year":"1975","unstructured":"Birkmayer W, Riederer P, Youdim MBH, Linauer W (1975) Potentiation of anti akinetic effect after l-dopa treatment by an inhibitor of MAO-B, deprenil. J Neural Trans 36:303\u2013326","journal-title":"J Neural Trans"},{"key":"666_CR3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(77)91940-7","volume":"1","author":"W Birkmayer","year":"1977","unstructured":"Birkmayer W, Riederer P, Ambrozi L, Youdim MBH (1977) Implications of combined treatment with madopar and l-deprenil in Parkinsons-disease\u2014long-term study. Lancet 1:439\u2013443","journal-title":"Lancet"},{"key":"666_CR4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000407513","volume":"19","author":"W Birkmayer","year":"1983","unstructured":"Birkmayer W, Knoll J, Riederer P, Youdim MB (1983) (\u2212)-Deprenyl leads to prolongation of l-dopa efficacy in Parkinson\u2019s disease. Mod Probl Pharmacopsychiatry 19:170\u2013176","journal-title":"Mod Probl Pharmacopsychiatry"},{"key":"666_CR5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01245973","volume":"64","author":"W Birkmayer","year":"1985","unstructured":"Birkmayer W, Knoll J, Riederer P, Youdim MBH, Hars V, Marton J (1985) Increased life expectancy resulting from addition of l-deprenyl to madopar treatment in Parkinsons-disease\u2014a longterm study. J Neural Trans 64:113\u2013127","journal-title":"J Neural Trans"},{"key":"666_CR6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/clinchem\/45.6.895","volume":"45","author":"A Blazovics","year":"1999","unstructured":"Blazovics A, Kovacs A, Lugasi A, Hagymasi K, Biro L, Feher J (1999) Antioxidant defense in erythrocytes and plasma of patients with active and quiescent Crohn disease and ulcerative colitis: a chemiluminescent study. Clin Chem 45:895\u2013896","journal-title":"Clin Chem"},{"key":"666_CR7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/gut.26.2.133","volume":"26","author":"A Braillon","year":"1985","unstructured":"Braillon A, Capron JP, Herv\u00e9 MA, Degott C, Quenum C (1985) Liver in obesity. Gut 26:133\u2013139","journal-title":"Gut"},{"key":"666_CR8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0024-3205(91)90466-O","volume":"48","author":"MC Carrillo","year":"1991","unstructured":"Carrillo MC, Kanai S, Nokubo M, Kitani K (1991) (\u2212) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats. Life Sci 48:517\u2013521","journal-title":"Life Sci"},{"key":"666_CR9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","volume":"114","author":"CP Day","year":"1998","unstructured":"Day CP, James OF (1998) Steatohepatitis: a tale of two \u201chits\u201d? Gastroenterology 114:842\u2013845","journal-title":"Gastroenterology"},{"key":"666_CR10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0163-7258(95)00012-6","volume":"67","author":"B Fromenty","year":"1995","unstructured":"Fromenty B, Pessayre D (1995) Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 67:101\u2013154","journal-title":"Pharmacol Ther"},{"key":"666_CR11","first-page":"65","volume":"20","author":"V Glover","year":"1986","unstructured":"Glover V, Gibb C, Sandler M (1986) The role of MAO in MPTP toxicity\u2014a review. J Neural Transm Suppl 20:65\u201376","journal-title":"J Neural Transm Suppl"},{"key":"666_CR12","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","volume":"82","author":"JA Javitch","year":"1985","unstructured":"Javitch JA, D\u2019Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1, 2, 3, 6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82:2173\u20132177","journal-title":"Proc Natl Acad Sci USA"},{"key":"666_CR13","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00702-005-0295-3","volume":"112","author":"V Jenei","year":"2005","unstructured":"Jenei V, Zor K, Magyar K, Jakus J (2005) Increased cell\u2013cell adhesion, a novel effect of R-(\u2212)-deprenyl. J Neural Transm 112:1433\u20131445","journal-title":"J Neural Transm"},{"key":"666_CR14","first-page":"393","volume":"5","author":"J Knoll","year":"1972","unstructured":"Knoll J, Magyar K (1972) Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol 5:393\u2013408","journal-title":"Adv Biochem Psychopharmacol"},{"key":"666_CR15","first-page":"154","volume":"155","author":"J Knoll","year":"1965","unstructured":"Knoll J, Ecseri Z, Kelemen K, Nievel J, Knoll B (1965) Phenylisopropylmethylpropinylamine (E-250), a new spectrum psychic energizer. Arch Int Pharmacodyn Ther 155:154\u2013164","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"666_CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-0348-6348-3_6","volume-title":"Inhibitors of Monoamine Oxidase B","author":"K Magyar","year":"1993","unstructured":"Magyar K (1993) Pharmacology of monoamine oxidase type-B inhibitors. In: Szel\u00e9nyi I (ed) Inhibitors of Monoamine Oxidase B. Pharmacology and clinical use in neurodegenerative disorders. Birkhauser Verlag, Basel, pp 125\u2013143"},{"key":"666_CR17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0161-813X(03)00102-5","volume":"25","author":"K Magyar","year":"2004","unstructured":"Magyar K, Szende B (2004) (\u2212)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties. Neurotoxicology 25:233\u2013242","journal-title":"Neurotoxicology"},{"key":"666_CR18","first-page":"377","volume":"32","author":"K Magyar","year":"1967","unstructured":"Magyar K, Vizi ES, Ecseri Z, Knoll J (1967) Comparative pharmacological analysis of the optical isomers of phenyl-isopropyl-methyl-propinylamine (E-250). Acta Physiol Acad Sci Hung 32:377\u2013387","journal-title":"Acta Physiol Acad Sci Hung"},{"key":"666_CR19","first-page":"29","volume":"48","author":"K Magyar","year":"1996","unstructured":"Magyar K, Szende B, Lengyel J, Tekes K (1996) The pharmacology of B-type selective monoamine oxidase inhibitors; milestones in (\u2212)-deprenyl research. J Neural Transm Suppl 48:29\u201343","journal-title":"J Neural Transm Suppl"},{"key":"666_CR20","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1007\/s11064-010-0238-8","volume":"35","author":"K Magyar","year":"2010","unstructured":"Magyar K, Szende B, Jenei V, Tabi T, Palfi M, Szoko E (2010) R-deprenyl: pharmacological spectrum of its activity. Neurochem Res 35:1922\u20131932","journal-title":"Neurochem Res"},{"key":"666_CR21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0024-3205(90)90299-7","volume":"47","author":"NW Milgram","year":"1990","unstructured":"Milgram NW, Racine RJ, Nellis P, Mendonca A, Ivy GO (1990) Maintenance on l-deprenyl prolongs life in aged male rats. Life Sci 47:415\u2013420","journal-title":"Life Sci"},{"key":"666_CR22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.410380512","volume":"38","author":"CW Olanow","year":"1995","unstructured":"Olanow CW, Hauser RA, Gauger L, Malapira T, Koller W, Hubble J, Bushenbark K, Lilienfeld D, Esterlitz J (1995) The effect of deprenyl and levodopa on the progression of Parkinson\u2019s disease. Ann Neurol 38:771\u2013777","journal-title":"Ann Neurol"},{"key":"666_CR23","first-page":"163","volume":"18","author":"A Ricci","year":"1992","unstructured":"Ricci A, Mancini M, Strocchi P, Bongrani S, Bronzetti E (1992) Deficits in cholinergic neurotransmission markers induced by ethylcholine mustard aziridinium (AF64A) in the rat hippocampus: sensitivity to treatment with the monoamine oxidase-B inhibitor l-deprenyl. Drugs Exp Clin Res 18:163\u2013171","journal-title":"Drugs Exp Clin Res"},{"key":"666_CR24","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1471-4159.1986.tb01747.x","volume":"46","author":"P Riederer","year":"1986","unstructured":"Riederer P, Youdim MB (1986) Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl. J Neurochem 46:1359\u20131365","journal-title":"J Neurochem"},{"key":"666_CR25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1476-5381.1976.tb08619.x","volume":"58","author":"SB Ross","year":"1976","unstructured":"Ross SB (1976) Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart. Br J Pharmacol 58:521\u2013527","journal-title":"Br J Pharmacol"},{"key":"666_CR26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.2042-7158.1976.tb04659.x","volume":"28","author":"SB Ross","year":"1976","unstructured":"Ross SB, Renyl AL (1976) On the long-lasting inhibitory effect of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP 4) on the active uptake of noradrenaline. J Pharm Pharmacol 28:458\u2013459","journal-title":"J Pharm Pharmacol"},{"key":"666_CR27","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1212\/WNL.47.6_Suppl_3.171S","volume":"47","author":"WG Tatton","year":"1996","unstructured":"Tatton WG, Chalmers-Redman RM (1996) Modulation of gene expression rather than monoamine oxidase inhibition: (\u2212)-deprenyl-related compounds in controlling neurodegeneration. Neurology 47:S171\u2013S183","journal-title":"Neurology"},{"key":"666_CR28","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1046\/j.1471-4159.1994.63041572.x","volume":"63","author":"WG Tatton","year":"1994","unstructured":"Tatton WG, Ju WY, Holland DP, Tai C, Kwan M (1994) (\u2212)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis. J Neurochem 63:1572\u20131575","journal-title":"J Neurochem"},{"key":"666_CR29","first-page":"45","volume":"48","author":"WG Tatton","year":"1996","unstructured":"Tatton WG, Wadia JS, Ju WY, Chalmers-Redman RM, Tatton NA (1996) (\u2212)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase. J Neural Transm Suppl 48:45\u201359","journal-title":"J Neural Transm Suppl"},{"key":"666_CR30","doi-asserted-by":"crossref","unstructured":"Tatton WG, Chalmers-Redman RM, Elstner M, Leesch W, Jagodzinski FB, Stupak DP, Sugrue MM, Tatton NA (2000) Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling. J Neural Transm Suppl (60):77\u2013100","DOI":"10.1007\/978-3-7091-6301-6_5"},{"key":"666_CR31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/jpet.301.2.753","volume":"301","author":"WG Tatton","year":"2002","unstructured":"Tatton WG, Chalmers-Redman RM, Ju WJ, Mammen M, Carlile GW, Pong AW, Tatton NA (2002) Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J Pharmacol Exp Ther 301:753\u2013764","journal-title":"J Pharmacol Exp Ther"},{"key":"666_CR32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1210\/en.136.3.1103","volume":"136","author":"S Thyagarajan","year":"1995","unstructured":"Thyagarajan S, Meites J, Quadri SK (1995) Deprenyl reinitiates estrous cycles, reduces serum prolactin, and decreases the incidence of mammary and pituitary tumors in old acyclic rats. Endocrinology 136:1103\u20131110","journal-title":"Endocrinology"},{"key":"666_CR33","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0047-6374(01)00391-8","volume":"123","author":"MB Youdim","year":"2002","unstructured":"Youdim MB, Weinstock M (2002) Novel neuroprotective anti-Alzheimer drugs with anti-depressant activity derived from the anti-Parkinson drug, rasagiline. Mech Ageing Dev 123:1081\u20131086","journal-title":"Mech Ageing Dev"},{"key":"666_CR34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1749-6632.2001.tb03656.x","volume":"939","author":"MB Youdim","year":"2001","unstructured":"Youdim MB, Wadia A, Tatton W, Weinstock M (2001) The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo. Ann NY Acad Sci 939:450\u2013458","journal-title":"Ann NY Acad Sci"},{"key":"666_CR35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/abbi.1996.9785","volume":"337","author":"RC Zangar","year":"1997","unstructured":"Zangar RC, Novak RF (1997) Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytes. Arch Biochem Biophys 337:217\u2013224","journal-title":"Arch Biochem Biophys"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0666-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-011-0666-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0666-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T21:37:01Z","timestamp":1592602621000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-011-0666-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["666"],"URL":"https:\/\/doi.org\/10.1007\/s00702-011-0666-x","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,5]]}}}